Connor, Clark & Lunn Investment Management Ltd. Optimize Rx Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Optimize Rx Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 30,944 shares of OPRX stock, worth $628,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,944Holding current value
$628,163% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OPRX
# of Institutions
133Shares Held
13.5MCall Options Held
223KPut Options Held
92.8K-
Whetstone Capital Advisors, LLC Shawnee Mission, KS1.51MShares$30.6 Million7.42% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA921KShares$18.7 Million0.0% of portfolio
-
Royce & Associates LP791KShares$16 Million0.12% of portfolio
-
Blair William & CO Chicago, IL629KShares$12.8 Million0.02% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $366M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...